People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Codexis, Inc. | — | Biotechnology | Series C | $50.0M | $2.0B | 2019 |
Pam Cheng at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Pam Cheng on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Smith | 1 | 42 |
| Thomas Baruch | 1 | 4 |
| Kathleen Glaub | 1 | 3 |
| Patrick Yang | 1 | 3 |
| Dennis Wolf | 1 | 3 |
| John Nicols | 1 | 2 |
| Gordon Sangster | 1 | 1 |
| Bernard Kelley | 1 | 1 |
| Byron Dorgan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.